46 results about "Immunofluorescent labeling" patented technology

The present invention provides are a gold nanoflower structure and a preparation method therefor. The gold nanoflower structure is a gold nanoflower particle, with round-head columns being uniformly distributed at the periphery thereof, obtained by using gold octahedrons, gold balls or gold tetrahedrons as seed crystals and reducing chloroauric acid by using weak reductant in an environment of high-concentration polyvinylpyrrolidone. In addition, also provided in the present invention are a gold nanoflower/quantum dot composite probe for living cell immunofluorescent labeling and photothermal therapy, a preparation method therefor and a use thereof. In comparison with traditional probes, the probe, incorporates the features of photothermal therapy and fluorescent labeling, and is capable of killing cancer cells in an effective and directional way. Two light sources are adopted to bring a tremendous photothermal conversion efficiency and a greater enhancement on fluorescence intensity of quantum dots respectively, thus mutual interference of two effects are avoided tactfully. The coating of silicon dioxide averts the biotoxicity of the gold nanoflower and the quantum dot effectually, enabling the surface of the composite probe to be easily functionalized and also imparting an extraordinarily excellent biocompatibility to the composite probe.

The invention discloses a 3D culture, passage, cryopreservation, recovery and identification method for in-vitro organoids based on small intestines of different segments of mice. The method comprisesthe following steps: (1) separating recesses of duodenum, jejunum and ileum segments of mice; (2) performing 3D culture on the recesses of the duodenum, jejunum and ileum segments of mice, and forming organoids; (3) performing passage on organoids of small intestines of mice; (4) performing cryopreservation on the organoids of small intestines of mice; (5) performing recovery on the organoids ofsmall intestines of mice; (6) preparing frozen sections of the organoids of small intestines of mice; and (7) performing immunofluorescence labeling and identification on the frozen sections of the organoids of small intestines of mice. Compared with the prior art, the method disclosed by the invention optimizes a recess extraction manner, an in-vitro culture system and a culture medium based on the recesses of the small intestines containing stem cells, and comprises the steps of complete culture, passage, cryopreservation, recovery and identification. The small intestine organoids obtained by the method are capable of performing repeated passage, and the passage organoids have character stability.

The invention relates to an immunofluorescent kit for detecting circulating tumor cells HER2, ER and PR and an application of the immunofluorescent kit. A detection principle of a method disclosed bythe invention is as follows: firstly, enriching circulating tumor cells and other rare cells, and then, detecting the expression of target proteins in the enriched cells in cells by using an immunofluorescene detection method according to an antigen-antibody reaction principle. According to the kit, a common antigen CD45 of a target cell and a leukocyte is fluorescently labeled, and the cells withpositive target proteins and negative CD45 are screened, so that the circulating tumor cells with positive specific proteins in the blood are interpreted and counted.

This invention discloses to a kind of immunofluorescence mark reagent box. It is a reagent box applied for the aspects of immunity mark which uses the green fluorescence protein (GFP) as the indicator, the staphylococcus protein A (SPA) as the antibody. It also discloses the preparation method of the reagent. This invention can applied wide range in the field such as the immunity fluorescence mark, immunity histochemistry, biochemistry analysis, antibody test, protein chip and so on. It can replace the exist product efficiently, its operation is more simple, stability, delicacy and reliability, it is especially the same with the high flux analysis which analyze by the fluorescence analysis instrument.

The invention discloses a method for analyzing tar-induced cell DNA (deoxyribonucleic acid) damage on the basis of quantitative analysis of the high content technology. The method includes the steps of 1), cell culture; 2), cell contamination; 3), immunofluorescent labeling of gamma H2AX; 4), quantitative analysis of high content technology. The method has the advantages that automatic imaging is performed by the aid of a high content imaging system, tar-induced gamma H2AX protein of DNA double-strand fracture markers is quantitatively analyzed, cells are detected directly and rapidly, and sample processing is facilitated; distribution of gamma H2AX in cell nucleuses can be observed directly and image materials are stored and reanalyzed conveniently through high-resolution imaging, the tar-induced gamma H2AX in each cell nucleus can be quantitatively analyzed, and detection results are more sensitive and accurate.

The invention provides application of fraxin in preparation of drugs for preventing or treating an acute respiratory distress syndrome (ARDS). The fraxin is a coumarins compound which is extracted from dry barks of oleaceae fraxinus chinensis, Fraxinus szaboana Lingelsh or Fraxinus stylosa Lingelsh. Existing researches show that the fraxin has effects of resisting inflammation, reducing blood uricacid, resisting bacteria and inducing diuresis. On the basis of constructing an anima damage model of acute respiratory distress syndrome, by HE, Evan blue staining, fluorescence probes, immunofluorescent labeling, western blotting and the like, it verifies that the fraxin can reduce generation and releasing of reactive oxygen (ROS), inhibit generation and releasing of inflammatory factors and inhibit activation of signal paths MAPKs, therefore, degradation of a blood vessel endothelial polysaccharide coating is relieved, and vascular permeability is relieved to prevent or treat ARDS.

The invention relates to the technical field of biology, in particular to an immunofluorescent labeling method for protein in a living cell. The method comprises the following steps of coupling an antibody fragment of protein to be labeled and a fluorescent dye to obtain a fluorescently-labeled antibody fragment; binding liposome and the fluorescently-labeled antibody fragment to obtain a transportable label; culturing a cell to be labeled and the transportable label in a culture medium, transporting the transportable label into the cell to be labeled by utilizing the characteristic that the liposome can be fused with a cell membrane, namely the membrane permeability of the liposome in a culturing process, and performing specific immune binding on the transportable label and the protein to be labeled in the cell to be labeled through an antigen binding fragment on the protein to be labeled, thereby connecting the fluorescent dye to the protein to be labeled to finally fulfill the aim of immunofluorescent labeling of the protein in the living cell.

The invention discloses a method for detecting protease-4 of a human airway trypsin sample by using flow cytometry. Specifically, the method comprises the following steps: (1) collecting a marrow or peripheral blood sample; (2) performing immunofluorescent labeling; (3) performing detection with a becton dickinson caliber. According to the detection method disclosed by the invention, a few of marrow cells canbe used as samples, and peripheralblood can be also used as a sample, so that pain of a patient in a sample collecting process can begreatly relieved, and the compliance of the patient is improved. Furthermore, the operation steps in the detection method disclosed by the invention are simple and convenient, and the detection period is short; the detection can be completed within only several hours; the detection period is greatly shortened, the progress of relevant researches can be accelerated favorably, and the time cost is reduced.

The invention provides a monoclonal antibody of anti-perkinsus membrane protein (MOE). The monoclonal antibody of the anti-perkinsus membrane protein (MOE) is secreted by a hybridoma cell strain IAQ1101 of the anti-perkinsus membrane protein (MOE) with an accession number of CGMCC (China General Microbiological Culture Collection) No.6180. The invention also provides a preparation method and application of the monoclonal antibody. The monoclonal antibody of the anti-perkinsus membrane protein (MOE) is obtained by a genetic engineering technology and an immunological method; by labeling the monoclonal antibody with fluorescence, the immunofluorescence labeling technology is utilized to quickly and accurately detect infected perkinsus in shellfish, accordingly, a reliable immunological detection method is provided for the rapid identification of a port.

The invention provides an application of neferine in the prevention or treatment of acute respiratory distress syndrome (ARDS). The neferine is alkaloid extracted from natural plants and has antioxidant activity. Based on the construction of animal and cell damage models of acute respiratory distress syndrome, by HE, Evan blue staining, fluorescent probe, immunofluorescence labeling and the like, it is verified that the neferine can reduce the production and release of reactive oxygen species (ROS) and reduce the degradation of vascular endothelium polysaccharide coating (Glycocalyx), thus the occurrence and development of ARDS are inhibited, and ARDS is prevented or treated.

The invention provides a same-section multi-target protein immunohistochemical or immunofluorescent labeling method. The method comprises the following steps of: unfolding slices in corresponding liquid in the process of slicing a tissue wax block, selecting two continuously connected slices in the process of catching a target slice, placing the back surface of the first slice upwards in the process of catching the slice by employing a glass slide, and placing the front surface upwards in the process of catching the second slice, so that the condition that the surfaces of the two tissue slice for staining belong to the same slicing surface is ensured; and respectively performing immunohistochemical or immunofluorescent staining on different target proteins for two slices from the same slicing surface, performing overlap comparison on the tissue staining result in a same area, so as to realize existential analysis of a same cell or tissue site multi-target protein. The effect of performing multi-target protein labeling on the same cell or tissue site to be detected is achieved.

The invention provides a precise immunofluorescence labeling method for a whole tissue sample, which comprises the following steps: fixing, pretreatment, transparentizing treatment, confining liquid confining, freeze thawing and primary antibody incubation, and secondary antibody incubation. Freeze thawing and ultrasonic incubation are adopted, so that the permeability of an optical transparentizing agent and the compatibility of fluorescent protein are increased, the resolution of a fluorescence image is increased, the permeability of a large tissue sample is realized, and the overall immunolabeling of an organ is achieved.

The invention discloses a method for quantitatively detecting 1,3-butadiene-induced cell DNA damage in combination with a gas-liquid interface exposure system and a high-content technology. The method comprises the following steps: 1) cell culture; 2) 1,3-butadiene exposure through a gas-liquid interface exposure mode; 3) immunofluorescent labeling of gamma H2AX; 4) high-content detection. The method disclosed by the invention has the advantages that the efficient exposure of gaseous 1,3-butadiene to wall-attached cells in vivo is realized by adopting the in-vitro gas-liquid interface exposure mode, so that the exposure efficiency of the 1,3-butadiene is improved; a high-content imaging system is utilized for automatic imaging, 1,3-butadiene-induced DNA double-chain fracture maker gamma H2AX proteins are quantitatively analyzed, and the direct and quick detection of the cells is realized, so that the sample treatment is more convenient; through high-resolution imaging, not only can the distribution of the gamma H2AX in cell nucleuses be directly observed, but also image data is convenient to store and re-analyze, and the quantitative analysis on the 1,3-butadiene-induced gamma H2AX in each of the cell nucleuses can be realized, so that detection results are more sensitive and accurate.

The present invention discloses an immunofluorescence labeling method for proteins in living cells, and relates to the field of biotechnology. The method comprises following steps: a cell smear is treated through 0.2% TritonX-100 for 10-15 minutes, is washed with 0.01 M PBS for 3-5 minutes, is washed for 3-5 times, is digested with a 0.01 trypsin solution at 37-40 degree Celsius for 12-15 min, iswashed with the 0.01 M PBS for 3 - 5 minutes, is washed for 3 - 5 times, then is blocked with normal rabbit serum, is added with FITC-goat-anti-mouse iGg, is incubated at 37-40 degree Celsius for 30-40 minutes, is washed with the 0.01 M PBS for 3 - 5 minutes, with BrdU used as a protein marker, and after fixed with cross-linking fixative, is observed under a fluorescence microscope. The method canobserve and detect a morphological structure, molecular and ion number of the living cells in real time, can simultaneously study a plurality of target proteins on one specimen, and is suitable for popularization and application.

The invention discloses a non-enveloped virus quantum dot marking method and application.The method comprises the steps that biotinylation virus suspension is centrifuged, and biotinylation non-enveloped viruses of the uniform structure are obtained; the viruses are inoculated into susceptible cells, quantum dots are added for incubation, and non-enveloped viruses marked with the quantum dots can be obtained.By means of the marked non-enveloped viruses, non-enveloped virus outer capsid protein immunofluorescence marking and cell specific component fluorescent protein positioning, dynamic tracking of a non-enveloped virus living body in the invasion process and positioning of interaction components of the non-enveloped viruses and host cells are achieved.The method can also be used for monitoring the host cell invasion path of the viruses in real time, and is particularly applicable to identifying the interaction components of fish non-enveloped viruses and host cells and also applicable to screening, research and development of fish reovirus resistance preparations.

The disclosure provides methods for detecting circular endothelial cells (CECs) in a non- enriched blood sample. The present disclosure is based, in part, on the unexpected discovery that CECs can be detected in non-enriched blood samples. The present disclosure is further based, in part, on the discovery that CECs can be detected in non-enriched blood samples by combining the detection of one or more immunofluorescent markers in the nucleated cells of a non-enriched blood sample with an assessment of the morphology of the nucleated cells. The present disclosure is further based, in part, on the discovery that CECs can be detected in non-enriched blood samples by comparing the immunofluorescent marker staining and morphological characteristics of CECs with the immunofluorescent marker staining and morphological characteristics of WBCs. The methods disclosed herein serve to classify human subject in myocardial infarction (MI) patients or healthy controls.

The invention relates to the technical field of detection, and particularly discloses application of combination of a tissue transparentizing method and a histological method in detection of bacteria in tumors. According to the invention, a tissue transparentizing method and a traditional histological method are combined for use, so that the limitation (several microns) on the thickness of a sample can be broken so as to avoid potential pollution on the surface of a thin slice, and a high-resolution and integral three-dimensional image of a large-size tissue sample can be completely constructed so as to achieve three-dimensional visualization of bacteria in tumors; and a tissue with a thickness of 500 microns is selected, optical transparency is achieved through a tissue transparentizing method, and a traditional histological method (such as an immunofluorescence labeling method) is combined for labeling bacteria in the tumor tissue, so that a more accurate experiment result is obtained, and a solid foundation is laid for researching the direct interaction between the microbial population and the tumor cells in the tumor microenvironment.

The invention discloses an immunochromatographic detection method based on a near-infrared luminescent rare earth nano-material, which uses the near-infrared luminescent rare earth nano-material as animmunofluorescent marker to mark and recognize antibodies for performing immunochromatographic detection. The near-infrared luminescent rare earth nano-material has the following characteristics: (1)both the excitation light and the emission light are located in the near-infrared light region from 700 to 1700 nm; (2) the excitation wavelength is less than the emission wavelength, and the excitation light is a positive Stokes shift luminescence, and the Stokes shift is greater than 150 nm; (3) the fluorescence quantum efficiency is higher than 1%; (4) the fluorescence lifetime is greater than10 microseconds; and (5) the light stability is better than organic dyes. By using the immunochromatographic detection method based on the near-infrared luminescent rare earth nano-material disclosedby the invention for immunochromatographic detection, the stability of the fluorescent marker is better, the fluorescence emission is stronger, and the detection result has better repeatability.

The invention discloses a method for quantitatively analyzing cell DNA damage induced by benzo[a]pyrene based on a high connotation technique. The method comprises the following steps: 1) performing cell culture; 2) infecting cells; 3) performing immunofluorescent labeling for gamma H2AX; and 4) performing quantitative analysis by adopting the high connotation technique. The method has the advantages that a high connotation imaging system is utilized for automatically imaging and quantitatively analyzing the gamma H2AX protein of a DNA double-strand breaking mark induced by benzo[a]pyrene, the direct and quick detection for cells is realized, and the sample treatment is more convenient; and due to high-resolution imaging, the distribution of gamma H2AX in a cell nucleus can be directly observed, the image data can be conveniently stored and analyzed, and the quantitative analysis for gamma H2AX, induced in each cell nucleus, of benzo[a]pyrene, can be realized, so that the detection result is more sensitive and accurate.

The invention provides an immunofluorescence method for locating a woody plant pollen tube protein and a kit thereof. The kit includes a fixing solution, an enzymolysis solution, a blocking solution,a primary antibody and a secondary antibody; the fixing solution contains PEPES, sucrose, Triton X-100, paraformaldehyde, NaCl, KCl, Na2HPO4 and KH2PO4, the enzymolysis solution contains cellulase, macerozyme, NaCl, KCl, Na2HPO4 and KH2PO4, the blocking solution contains bovine serum albumin, NaCl, KCl, Na2HPO4 and KH2PO4, the primary antibody is a target protein antibody, and the secondary antibody is a FITC-labeled goat anti-rabbit secondary antibody. The method adopts an apple pollen tube as a test material, after enzymatic hydrolysis of the wall of the apple pollen tube, immunofluorescentlabeling is performed. The method can directly, efficiently, sensitively and specifically locate the functional protein in the pollen tube, and provides a technical system for visually identifying theexpression of the functional protein in the pollen tube of a woody plant and locating the functional protein in the pollen tube of the woody plant.

The invention relates to the technical field of clinical medicine, in particular to a prognostic evaluation method for hepatocellular carcinoma through Telocytes, which comprises the following steps: taking a postoperative tumor specimen of a hepatocellular carcinoma patient, preparing a frozen section or a paraffin section from a cancer cell para-tissue within a range of 1-2cm from the tumor, carrying out immunofluorescent staining by using CD34 (highly glycosylated I-type transmembrane glycoprotein)/CD117 (III-type transmembrane kinase receptor protein)/PDGFR (platelet-derived growth factor receptor)/vimentin (waveform fibrin) indexes, taking CD34 +/CD117 +/PDGFR +/vimentin-cells as TCs cells, putting para-carcinoma tissues into a general stationary liquid for an electron microscope, performing slicing, and observing the morphology of the TCs cells under a transmission electron microscope. According to the prognostic evaluation method for the hepatocellular carcinoma through the Telocytes, multiple groups of double immunofluorescence markers are adopted, and the cell morphology and the telomere number are observed, so that accurate indexes for prognostic evaluation of patients can be provided for clinicians, and the problem of probability of prognostic evaluation indexes of the patients with the hepatocellular carcinoma is solved.